Citation, DOI, disclosures and article data
At the time the article was created Francis Deng had no recorded disclosures.View Francis Deng's current disclosures
At the time the article was last revised Daniel J Bell had no recorded disclosures.View Daniel J Bell's current disclosures
Mucosal melanomas are non-cutaneous malignant melanomas arising from mucosal epithelium.
This article is an overview; for specific locations in the body, see their respective articles: sinonasal mucosal melanoma.
Mucosal melanomas are rare, comprising about 1% of all melanomas 1. The median age of diagnosis is 70 years, higher than that of cutaneous melanomas 2. There are no known environmental risk factors.
The histogenesis of melanomas, including mucosal melanomas, is from melanocytes.
Mucosal melanoma can arise from any mucosal epithelium in the body. The most common locations are the following 1:
- head and neck (55%), most commonly sinonasal, followed by oral cavity
- anorectum (24%)
- female genital tract (18%)
- urinary tract (3%)
Up to 40% of mucosal melanomas are amelanotic, meaning the tumors are at least partially devoid of the melanin pigment 2.
Staging system differs depending on the primary site of disease 2. Head and neck tumors are staged by the American Joint Committee on Cancer TNM system. Melanomas of the external lip and vulva are staged as cutaneous melanomas. Anorectal and vaginal tumors do not have a specifically designed staging system but can be categorized by the following system originally introduced by Ballantyne for the head and neck 3:
- stage I: clinically localized disease
- stage II: regional lymph node involvement
- stage III: distant metastases
T1 hyperintensity is characteristic, reflecting melanin, but not universal, likely due to amelanosis 4.
Treatment and prognosis
Treatment typically consists of surgical excision and radiation therapy. Decisions for systemic chemotherapy are based on limited evidence, often extrapolated from cutaneous melanoma. The prognosis is poor, with a five-year overall survival of 25% 1.
- 1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. (1998) Cancer. 83 (8): 1664-78. Pubmed
- 2. Carvajal RD, Spencer SA, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. (2012) Journal of the National Comprehensive Cancer Network : JNCCN. 10 (3): 345-56. Pubmed
- 3. Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. (1970) American journal of surgery. 120 (4): 425-31. Pubmed
- 4. Yoshioka H, Kamada T, Kandatsu S, Koga M, Yoshikawa K, Matsuoka Y, Mizoe J, Itai Y, Tsujii H. MRI of mucosal malignant melanoma of the head and neck. (1998) Journal of computer assisted tomography. 22 (3): 492-7. Pubmed